NANOBIOTIX to Participate in Investor Conferences the Week of November 10th
Rhea-AI Summary
NANOBIOTIX (NASDAQ: NBTX) announced that company management will participate in investor fireside chats the week of November 10, 2025.
Presentations and presenters:
- UBS Global Healthcare Conference — Monday, November 10, 2025 at 5:00 PM ET / 11:00 PM CET — Palm Beach Gardens, FL — Presenter: Bart van Rhijn, Chief Financial & Business Officer
- Guggenheim Annual Healthcare Innovation Conference — Monday, November 10, 2025 at 4:30 PM ET / 10:30 PM CET — Boston, MA — Presenter: Laurent Levy, Chief Executive Officer
- Stifel Healthcare Conference — Thursday, November 13, 2025 at 8:00 AM ET / 2:00 PM CET — New York, NY — Presenters: Laurent Levy and Bart van Rhijn
All fireside chats will be webcast live from the company Investors events page, with replays available after each event.
Positive
- None.
Negative
- None.
News Market Reaction – NBTX
On the day this news was published, NBTX gained 9.21%, reflecting a notable positive market reaction. Argus tracked a peak move of +6.5% during that session. Argus tracked a trough of -7.7% from its starting point during tracking. Our momentum scanner triggered 18 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $85M to the company's valuation, bringing the market cap to $1.01B at that time.
Data tracked by StockTitan Argus on the day of publication.
PARIS and CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in fireside chats at following conferences:
UBS Global Healthcare Conference
Date: Monday, November 10, 2025
Time: 5pm ET / 11pm CET
Location: Palm Beach Gardens, FL
Presenter: Bart van Rhijn, Chief Financial & Business Officer of Nanobiotix
Guggenheim’s Annual Healthcare Innovation Conference
Date: Monday, November 10, 2025
Time: 4:30pm ET / 10:30pm CET
Location: Boston, MA
Presenter: Laurent Levy, Chief Executive Officer of Nanobiotix
Webcast link: Click here
Stifel Healthcare Conference
Date: Thursday, November 13, 2025
Time: 8am ET / 2pm CET
Location: New York, NY
Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial & Business Officer of Nanobiotix
The recorded fireside chats will be webcast live from the events page of the Investors section of the Company’s website. Replay of the webcast will be available following the event.
About NANOBIOTIX
Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity. The Company’s philosophy is rooted in the concept of pushing past the boundaries of what is known to expand possibilities for human life.
Incorporated in 2003, Nanobiotix is headquartered in Paris, France and is listed on Euronext Paris since 2012 and on the Nasdaq Global Select Market in New York City since December 2020. The Company has subsidiaries in Cambridge, Massachusetts (United States) amongst other locations.
Nanobiotix is the owner of more than 25 patent families associated with three (3) nanotechnology platforms with applications in 1) oncology; 2) bioavailability and biodistribution; and 3) disorders of the central nervous system.
For more information about Nanobiotix, visit us at www.nanobiotix.com or follow us on LinkedIn and Twitter.
Contacts
| Nanobiotix | |||
| Communications Department Brandon Owens VP, Communications +1 (617) 852-4835 contact@nanobiotix.com | Investor Relations Department Joanne Choi VP, Investor Relations (US) +1 (713) 609-3150 Ricky Bhajun Director, Investor Relations (EU) +33 (0) 79 97 29 99 investors@nanobiotix.com | ||
| Media Relations | |||
France – HARDY Caroline Hardy +33 06 70 33 49 50 carolinehardy@outlook.fr | Global – uncapped Becky Lauer +1 (646) 286-0057 uncappednanobiotix@uncappedcommunications.com | ||
Attachments
- 2025-11-03 -- NBTX -- Presenting @ November Conferences -- FINAL
FAQ
When will NANOBIOTIX (NBTX) present at the UBS Global Healthcare Conference?
How can investors watch NANOBIOTIX (NBTX) fireside chats from November 10–13, 2025?
Who will represent NANOBIOTIX (NBTX) at Guggenheim’s Annual Healthcare Innovation Conference on November 10, 2025?
Which NANOBIOTIX (NBTX) executives will appear at the Stifel Healthcare Conference on November 13, 2025?
What dates should investors note for NANOBIOTIX (NBTX) investor events the week of November 10, 2025?
